9401:TSETBS HOLDINGS INC. Analysis
Data as of 2026-05-22 - not real-time
¥5,959.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
TBS Holdings,Inc. is trading at ¥5,959, comfortably above its 20‑day and 50‑day simple moving averages, indicating a continued upward bias. The MACD histogram remains positive and the signal line is bullish, while the RSI sits in the mid‑50s, suggesting momentum is still intact but not overbought. Volume has been increasing, supporting the price advance and reducing short‑term execution risk. Valuation metrics show a price‑to‑book below one and a dividend yield of roughly 1.7% with a payout ratio near 30%, pointing to an attractive income profile. Although the forward PE is higher than the sector average, the company’s modest revenue growth and solid free cash flow underpin its earnings stability. The low beta of around 0.35 and a 30‑day volatility near 25% reflect a defensive characteristic relative to the broader market.
On the fundamentals side, the balance sheet is cash‑rich with a debt‑to‑equity ratio that, while elevated, is manageable given the strong operating cash flow. The diversified mix of media, lifestyle, and real‑estate operations provides multiple revenue streams that can cushion sector‑specific headwinds. Analysts consensus remains a “Buy” with a median target near ¥6,030, implying modest upside potential of roughly 3%. The dividend policy appears sustainable, as earnings and cash generation comfortably cover the payout. Given the defensive beta, stable dividend and undervalued book value, the stock is well‑positioned for risk‑adjusted returns. Investors should consider adding the stock on dips, while keeping an eye on any macro‑economic shifts that could affect advertising spend.
On the fundamentals side, the balance sheet is cash‑rich with a debt‑to‑equity ratio that, while elevated, is manageable given the strong operating cash flow. The diversified mix of media, lifestyle, and real‑estate operations provides multiple revenue streams that can cushion sector‑specific headwinds. Analysts consensus remains a “Buy” with a median target near ¥6,030, implying modest upside potential of roughly 3%. The dividend policy appears sustainable, as earnings and cash generation comfortably cover the payout. Given the defensive beta, stable dividend and undervalued book value, the stock is well‑positioned for risk‑adjusted returns. Investors should consider adding the stock on dips, while keeping an eye on any macro‑economic shifts that could affect advertising spend.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover
- Increasing volume
- Price above 20‑day SMA
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued price‑to‑book
- Sustainable dividend yield
- Low beta defensive profile
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Diversified business segments
- Stable cash flow generation
- Moderate growth outlook
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin12.29%
P/E Ratio21.8
ROE5.07%
ROA1.06%
Debt/Equity6.53
P/B Ratio0.8
Op. Cash Flow¥10.1B
Free Cash Flow¥83.4M
Industry P/E17.1
Technical Analysis
TrendBullish
RSI57.8
Support¥5,470.00
Resistance¥6,209.00
MA 20¥5,744.80
MA 50¥5,712.40
MA 200¥5,629.80
MACDBullish
VolumeIncreasing
Fear & Greed Index91.39
Valuation
Fair Value¥327.13
Target Price¥6,123.33
Upside/Downside2.76%
GradeUndervalued
TypeValue
Dividend Yield1.69%
Risk Assessment
Beta0.35
Volatility25.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.